藥物成份

共有 21679 個藥物成份

#11018:\n1. < 5.0% Digoxin ANTISERUM (Rabbit) in buffer containing protein as stabilizer and < 0.1% sodium azide as preservative (3 ml)\n2. < 0.1% Digoxin-fluorescein TRACER in buffer containing protein as stabilizer, a surfactant and < 0.1% sodium azide as preservative (3 ml)\n3. PRE-TREATMENT BUFFER containing < 0.1% sodium azide as preservative (3 ml)\n4. PRECIPITATION REAGENT containing < 1.0% polyvinylsulfonic acid and < 1.0% sulfuric acid in < 25% methanol (30 ml)\n \n#41023: human serum and < 0.1% sodium azide as preservative\n

• 關聯藥證數量: 1

#11261 P：DIL： 2x40 ml RF Diluent\nTris (PH7.5) 87.5 mmol/l\nPEG 6000 2.5% W/V\nPreservatives\nRGT：2x10 ml RF Reagent，IgG solution \nHuman IgG approx.1.75 mg/dl\nPreservatives\n#11361\nSTD：2x3 ml RF Standard\nReady to use (human IgG)\nRF concentration is stated on the vial label.

• 關聯藥證數量: 1

#11731297 122\nM Streptavidin-coated microparticles (transparent cap), 1 bottle, 12 mL:\n Streptavidin-coated microparticles 0.72 mg/mL; preservative.\nR1 Anti-T4-Ab~Ru(bpy)2+3 (gray cap), 1 bottle, 18 mL:\n Polyclonal anti-T4-antibody (sheep) labeled with ruthenium complex\n 50 ng/mL; phosphate buffer 100 mmol/L, pH 7.0; preservative.\nR2 T4~biotin (black cap), 1 bottle, 18 mL:\n Biotinylated T4 2.5 ng/mL; phosphate buffer 100 mmol/L,\n pH 7.0; preservative.\n\n#11731661 122\n&#8226; FT4 Cal1: 2×1 mL\n&#8226; FT4 Cal2: 2×1 mL\nL-thyroxine in two concentration ranges (approx. 10 pmol/L or 0.78 ng/dL and approx. 45 pmol/L or 3.5 ng/dL) in buffer/protein (bovine serum albumin) matrix.

• 關聯藥證數量: 1

#12145383 122\nM Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5 mL:Streptavidin-coated microparticles 0.72 mg/mL;preservative.\nR1 Anti-progesterone-Ab~biotin (gray cap), 1 bottle, 10 mL:Biotinylated monoclonal anti-progesterone antibody (mouse) 0.15 mg/L;phosphate buffer 25 mmol/L, pH 7.0; preservative.\nR2 Progesterone-peptide~Ru(bpy)2+3 (black cap), 1 bottle, 8 mL:Progesterone (of vegetable origin) coupled to a synthetic peptide labeled with ruthenium complex, 10 ng/mL; phosphate buffer 25 mmol/L, pH 7.0; preservative.\n\n#12145391 122\nPROG II Cal1: 2 x 1 mL\nPROG II Cal2: 2 x 1 mL\nProgesterone (from plant material) in two concentration ranges (approx. 0.6 nmol/L or 0.2 ng/mL and approx. 169 nmol/L or 53 ng/mL) in a human serum matrix.

• 關聯藥證數量: 1

#1E02-20\nR1: 3x18 mL\nR2: 3x6 mL\nR1: TRIS: 100 mmol/L，Polyethylene Glycol: 50 g/L，Sodium Azide: 0.1%。\nR2: Anti-human prealbumin goat serum: 30%，TRIS: 100 mmol/L，Sodium Azide: 0.1%。\n

• 關聯藥證數量: 1

#1E09-20:\nReagent1 (R1): 2x38 mL\nReagent2 (R2): 2x21 mL\nR1: Mouse monoclonal antibodies to theophylline<0.1%，NAD>15 mmol/L，G6P<38 mmol/L，Sodium Azide 0.1%。\nR2: Theophylline-G6PDH<0.1%，TRIS Buffer>80 mmol/L，Sodium Azide 0.1%。

• 關聯藥證數量: 1

#1E12-20\n？Reagent 1 (R1): 2 x 38 mL\n？Reagent 2 (R2): 2 x 21 mL\nR1: Mouse monoclonal antibodies to carbamazepine: <0.1%，NAD:>15 mmol/L，G6P:<38 mmol/L，Sodium Azide: 0.1%。\nR2: Carbamazepine-G6PDH:<0.1%，TRIS buffer:>80 mmol/L，Sodium Azide:0.1%。

• 關聯藥證數量: 1

#210-0003: 1 Analytical Cartridge(s) (stainless steel cation exchange micro-cartridge, housed in a green adaptor)\n#210-0004: 1 x 950 mL Reagent A\n(contains a Bis-Tris buffer with 0.02% sodium azide as a preservative)\n#210-0005: 1 x 455 mL Reagent B\n(contains a Bis-Tris, sodium chloride buffer, with 0.02% sodium azide as a preservative)\n#210-0006: 1 x 125 mL Hemolysis Reagent \n(contains a Bis-Tris, saponin reagent, with 0.02% sodium azide as a preservative)\n#210-0061: 100 sample vials.\n

• 關聯藥證數量: 1

#21219 VITEK 2 Accessories kit\n#69285 Polystyrene tubes (12 x 75 mm)

• 關聯藥證數量: 1

#231213: Clindamycin 2μg, 1 cartridge, #231275: Clindamycin 2μg, 10 cartridges.

• 關聯藥證數量: 1

#2485: AccuPROBE MYCOBACTERIUM AVIUM \n COMPLEX PROBE KIT\n#2800: AccuPROBE CULTURE IDENTIFICATION \n REAGENT KIT\n#1791: GEN-PROBE DETECTION REAGENT KIT \n

• 關聯藥證數量: 1

#259846 & #259847: Lyophilized thromboplastin reagent from cultured human cells; contains calcium ions, buffers, stabilizers, and preservatives.\n#259872: Lyophilized thromboplastin reagent from cultured human cells; contains blue dye, calcium ions, buffers, stabilizers, and preservatives.\n

• 關聯藥證數量: 1

#310310：\nMagnetic particles(2.3 mL), Calibrator 1(2.1 mL), Calibrator 2(2.1 mL), Specimen diluent(28 mL), Conjugate(23 mL)

• 關聯藥證數量: 1

#310311：\nNegative control(2x0.9ml), Positive control(2x0.9ml)

• 關聯藥證數量: 1

#310700:\nMagnetic particles (2.3mL) : Magnetic particles coated with inactivated Toxoplasma gondii (RH strain) obtained from sonicated and detergent-extracted trophozoites, BSA, phosphate buffer,<0.1% sodium azide.\nCalibrator 1 (2.7mL ): Human serum/plasma containing low Toxoplasma gondii IgG levels, BSA, phosphate buffer, preservatives, an inert yellow dye.\nCalibrator 2 (2.7mL) : Human serum/plasma containing high Toxoplasma gondii IgG levels, BSA, phosphate buffer, preservatives, an inert blue dye.\nSpecimen diluent (2X28mL) : BSA, phosphate buffer, preservatives, an inert yellow dye.\nConjugate (28mL) : Mouse monoclonal antibodies to human IgG conjugated to an isoluminol derivative, BSA, phosphate buffer, preservatives.\n\n#310701:\nNegative control (0.6mL) : Human serum/ plasma without Toxoplasma gondii IgG antibodies, stabilized in PBS buffer, BSA, preservatives.\nPositive control (0.6mL) : Human serum/ plasma containing Toxoplasma gondii IgG antibodies, stabilized in PBS buffer, BSA, preservatives,

• 關聯藥證數量: 1

#3303: Coxsackievirus B Blend (2.0 mL); mouse monoclonal antibodies against the coxsackie B viruses. #3311: Echovirus Blend (2.0 mL); mouse monoclonal antibodies against echovirus types 4, 6, 9, 11, 30 and 34. #3321: Enterovirus 70/71 Blend (2.0 mL): mouse monoclonal antibodies against enteroviruses 70 and 71. #3336: Poliovirus Blend (2.0 mL): mouse monoclonal antibodies against polioviruses 1,2 and 3. #3360: Pan-Enterovirus Blend (5.0 mL): a blend of two mouse monoclonal antibodies which recognize all enteroviruses including echoviruses, coxsackie A and B viruses, polio 1,2, and 3, and enteroviruses 70 and 71.

• 關聯藥證數量: 1

#371465: Antibody sensitizing Latex suspension (18mL×2) Antihuman hemoglobin sheep antibody sensitized latex (2mg/mL).\n#37147-2: Hemoglobin buffer (250 mL).\n#37148-9: Calibrator (1 mL×8). \n#40998-4: Control (1 mL×8).

• 關聯藥證數量: 1

#402-01：0.75% kaolin, 0.0025M CaCl2,HEPES buffer,\n#550-09：The control is made of lyophilized citrated sheep plasma and erythrocytes.\n#550-11：0.1M CaCl2

• 關聯藥證數量: 1

#402-02：2.2% kaolin,0.05M CaCl2,HEPES buffer,#550-10：THe control is made of lyophilized citrated sheep plasma and erythrocytes.

• 關聯藥證數量: 1

#430-34491:\nCitrate buffer solution (pH 3.8) containing BCG and surfactant\n#431-53101/#419-30601:\nCitrate buffer 50 mmol/l\nBromocresol green 0.2 mmol/l\nSurfactant

• 關聯藥證數量: 1

#445923:空白\n#441049: fluorescent dye (tris-4, 7-diphenyl-1, 10-phenanthroline ruthenium dichloride pentahydrate-DPPRDP)

• 關聯藥證數量: 1

#5001/2 Mobile Phase 1000 ml/10 x 1000 ml: methanol solution of different salts 3-19%; #5001/k MobilePhase 1000 ml: acetonitrile <6%, isopropanol <1%, dibutylamin aqueous solution of different salts <0.1%; #5003 Calibration Standard 10 ml: aqueous solution of different salts; #5004 Internal Standard 10 ml: aqueous solution of different salts; #5011 Extraction Buffer 100 ml: Tris (hydroxymethyl) aminomethane >20%, EDTA <1%; #5005 Wash Buffer 1 x 300 ml: aqueous solution of different salts; #5006 Elution Buffer 25 ml: Acetic acid <5%; #5007 Sample Clean Up Columns 50 pcs: modified anorganic oxide; #5009 Plasma calibrator 10 x 2.5 ml: human plasma; #5100/#5100/K HPLC column 125 x 4.6 mm: modified Silicondioxide; #6003 Calibration Standard 10 ml: aqueous solution of different salts; #6004 Internal Standard 10 ml: aqueous solution of different salts; #6005 Dilutioon Buffer 300 ml: aqueous solution of different salts; #6055 Neutralisation Buffer 300 ml: aqueous solution of different salts; #6006 Elution Buffer 300

• 關聯藥證數量: 1

#550-07: The controls are made of lyophilized citrated sheep plasma and erythrocytes.

• 關聯藥證數量: 1

#55561 ID color Catalase 2x5 ml dropper bottles\n#55601 ONPG Discs 1 bottle of 30 discs (9 mm)\n#55622 Cefinase Cartridge of 50 discs\n#55635 Oxidase Reagent\n -50 ampoules with 0.75 ml of reagent per ampoule\n -1 reusable ampule crusher\n#55902 Bacitracin Test 2 bottles of 15 discs (6 mm)\n#55912 Optochin Test 2 bottles of 30 discs (9 mm)\n#56541 ID indole TDA\n -reagent R1：1x2.5 ml dropper bottle\n -reagent R2：1x2.5 ml dropper bottle\n

• 關聯藥證數量: 1

#58810 Slidex Strepto-Kit\n #58814 Slidex Strepto Extraction Enzyme \n #58815 Slidex Strepto A\n #58816 Slidex Strepto B\n #58817 Slidex Strepto D\n

• 關聯藥證數量: 1

#61036 Bili T:\nReagent 1: Sulfanilic acid DMSO 4x80 ml (liquid)\nReagent 2: Sodium nitrite 2x14 ml (liquid)\n#61037 Bili T/D:\nReagent 1: Sulfanilic acid DMSO 2x80 ml (liquid)\nReagnet 2: Sulfanilic acid 2x80 ml (liquid)\nReagent 3: Sodium nitrite 2x14 ml (liquid)

• 關聯藥證數量: 1

#6111300 Chlamydia pneumoniae IgG EIA 96 wells\n#6111310 Chlamydia pneumoniae IgA EIA 96 wells\n#6111320 Chlamydia pneumoniae IgM EIA 96 wells\n#6108380 Chlamydia pneumoniae IgG/IgM MIFA 20x21 wells\n#6108382 Chlamydia pneumoniae IgG/IgM MIFA 20x12 wells\n#6108390 Chlamydia pneumoniae IgA MIFA 20x21 wells\n#6108392 Chlamydia pneumoniae IgA MIFA 20x12 wells\n#6108384 Chlamydia pneumoniae slides 5x21 wells

• 關聯藥證數量: 1

#6801741:\nR1: None\nR2: Goat antisera to human prealbumin 1 mL/mL。\n#6801707 #6801771 #6801772:\nare prepared from processed human serum

• 關聯藥證數量: 1

#6802156:\n-100 coated wells (streptavidin source, bacterial; binds≧3 ng biotin/well).\n-8.2 mL conjugate reagent ((HRP-sheep polyclonal anti-NT-proBNP, binds≧37,000 pg NT-proBNP/mL (≧4,366 pmol NT-proBNP/L) in buffer with bovine serum albumin and antimicrobial agent.\n-8.2 mL biotinylated antibody reagent (biotin-sheep polyclonal anti-NT-proBNP, binds≧37,000 pg NT-proBNP/mL≧4,366 pmol NT-proBNP/L) in buffer with sheep serum, bovine serum albumin, bovine gamma globulin and antimicrobial agent.\n#6802157:\n- 2 mL in buffer with bovine serum albumin and antimicrobial agent; nominal values 0, 150, 12,500 pg/mL (0, 17.7, 1475 pmol/L). \n

• 關聯藥證數量: 1

#6802218:Reagent Ingredients:Reagent 1 (R1): NoneReagent 2 (R2): Latex particles coated with streptolysin O antigen, 0.17% (w/w) Other Ingredients Reagent 1 (R1): Preservatives, buffer, inorganic salt, protein Reagent 2 (R2): Preservative, buffer, inorganic salt, protein #6802323: aqueous solution containing processed human serum, bovine serum albumin, inorganic salt, and preservative.#6802411, #6802412: processed human serum to which purified human proteins, bovine serum albumin and preservative have been added.#6801784: processed water.#6801873: sodium chloride (154mM) and processed water.

• 關聯藥證數量: 1

#6C19-10\n3 Bottle (8.0 mL each) of ARCHITECT Toxo IgG Controls：\n Target Anti-Toxo IgG \n Concentration Control Range\nControl Color (IU/mL) (IU/mL)\nCONTROL - Natural N/A &#8804;0.5\nCONTROL 1 + Natural 6.0 3.0 – 9.0\nCONTROL 2 + Natural 120.0 60.0 -180.0

• 關聯藥證數量: 1

#6C19\nMicroparticle：1 Bottle Recombinant Toxoplasma gondii antigen coated microparticles in MES buffer with protein stabilizers.\nConjugate：1 Bottle Murine acridinium-labeled anti-human IgG in MES buffer with protein stabilizers.\nAssay Diluent：1 Bottle Toxo IgG assay diluent containing TRIS buffer with protein stabilizers.

• 關聯藥證數量: 1

#6E57-20:human prealbumin in human serum.\nCAL 1: 1 x 1 mL\nCAL 2: 1 x 1 mL\nCAL 3: 1 x 1 mL\nCAL 4: 1 x 1 mL\nCAL 5: 1 x 1 mL

• 關聯藥證數量: 1

#6E89-02: Sodium azide (0.1%) is present as a preservative.\nCAL1: 1 x 5 mL\nCAL2: 1 x 2 mL \nCAL3: 1 x 2 mL\nCAL4: 1 x 2 mL\nCAL5: 1 x 2 mL\nCAL6: 1 x 2 mL

• 關聯藥證數量: 1

#6E90-02:Carbamazepine Calibrator is prepared in an aqueous solution. Sodium azide (0.1%) is present as a preservative.\nCAL1: 1 x 5 mL\nCAL2: 1 x 2 mL\nCAL3: 1 x 2 mL\nCAL4: 1 x 2 mL \nCAL5: 1 x 2 mL\nCAL6: 1 x 2 mL\n

• 關聯藥證數量: 1

#760-2132: 1-25 ml dispenser CONFIRM anti-ER (6F11); contains approximately 25 μg of a mouse-anti-human monoclonal antibody directed against ER antigen.\n#760-2131: 1-25 ml dispenser Anti-PgR; contains approximately 25 μg of a mouse-anti-human monoclonal antibody directed against PgR antigen.\n

• 關聯藥證數量: 1

#7D58-20: 10 x 53 mL\n#7D58-30: 4 x 53 mL\n\nReactive Ingredients\n\n2-Chloro-4-Nitrophenyl-α-D-Maltotrioside 2.25 mmol/L\nSodium Chloride 350 mmol/L\nCalcium Acetate 6 mmol/L\nPotassium Thiocyanate 900 mmol/L\nSodium Azide 0.1﹪ \n

• 關聯藥證數量: 1

#7D79-20 (R1: 10x53 mL; R2: 10x15 mL)#7D79-30 (R1: 3x18 mL; R2: 3x6 mL)R1: Carbonate Buffer 100 mmol/L Sodium Chloride 200 mmol/LR2: Benzethonium Chloride 20g/L#1E71-02: 5x5 mL (10,20,40,80, and 200 mg/dL)The Urine/CSF Calibrator is a human protein based solution. Preservatives are also present.

• 關聯藥證數量: 1

#86081: \n1. Antibody Reagent:\n2.0 mL of antibody monospecific for human serum protein.\n2. Polymer Diluent:\n50 mL of a polymeric enhancer solution.\n3. Saline Diluent:\n80 mL of saline diluent.\n#86100:\n1. Standards for Serum proteins (1-5):\n1 mL of pooled normal human serum.\n2. Normal Human Serum Control-1 vial\n1 mL of pooled normal human serum\n\n

• 關聯藥證數量: 1

#86083\n1. Antibody Reagent: antibody monospecific for C-reactive protein contains 0.1% sodium azide.\n2. Antibody Diluent (Polymer Diluent II): 60 ml of a polymeric enhancer solution contains 0.1% sodium azide\n3. Saline Diluent: 50 ml saline diluent contains 0.1% sodium azide\n#86108 \n1. Standards for CRP (1-5): each vial of standard contains 2 ml of concentrated pooled human serum with purified CRP added. The assigned concentration of CRP for each standard is indicated on the lot-specific values insert\n2. CRP Control-1 vial: the control contains 2 ml of pooled human serum with purified CRP added.\n

• 關聯藥證數量: 1

#8K41-01\n6 Bottles (4 mL each) of ARCHITECT Insulin Calibrators. Calibrator A contains acetate buffer. Calibrators B-F contain insulin. The calibrators yield the following concentrations：\nCalibrator Isulin Concentration Calibrator\n (μU/mL) (pmol/L)\nCAL A 0 0\nCAL B 3 21.53\nCAL C 10 71.75\nCAL D 30 215.3\nCAL E 100 717.5\nCAL F 300 2153\n

• 關聯藥證數量: 1

#8K41-10\n3 bottles (8 mL each) of ARCHITECT Insulin Controls contain insulin prepared in Acetate buffer to yield the following concentration.\n Target concentration Range\nControl μU/mL pmol/L μU/mL pmol/L\nCONTROL L 8 57.4 5.6-10.4 40.2-74.6\nCONTROL M 40 287 28-52 201-373\nCONTROL H 120 861 84-156 603-1119

• 關聯藥證數量: 1

#8K41-25\nMicroparticles：1 Bottle (6.6 mL) Microparticles：Antibody to human insulin coated microparticles in MOPS buffer with protein stabilizer. Minimum concentration：0.08% solids.\nConjugate：1 Bottle (5.9 mL) Conjugate：Acridinium-labeled antibody to human insulin conjugate in MES buffer with protein stabilizer. Minimum concentration：0.09 μg/mL.

• 關聯藥證數量: 1

#8k27-01\n6 Bottles (2.0 mL each) of ARCHITECT DHEA-S Calibrators. Calibrator A contains human serum. Calibrators B-F contain DHEA-S (synthetic) in human serum\n\nCalibrator Target concentrationCalibrator (μg/dL)\nCAL A 0.0\nCAL B 5.0\nCAL C 12.0\nCAL D 60.0\nCAL E 300.0\nCAL F 1500.0\n

• 關聯藥證數量: 1

#8k27-10\n3×1 Bottle (4.0 mL each) of ARCHITECT DHEA-S Controls contain DHEA-S (synthetic) in human serum\n\n Targetconcentration Range\nControl (μg/dL) (μg/dL)\nCONTROL L 10 5.5-14.5\nCONTROL M 100 65.0-135.0\nCONTROL H 1000 650.0-1350.0\n\n#8k27-20/25 = 4×100 tests/100tests\n

• 關聯藥證數量: 1

#AP7926：R1. Buffer 2-amino-2-methyl-1-propanol Mg2+ ;R2. Substrate p-nitrophenylphosphate ; #AP502：1. Buffer Diethanolamine buffer MgCl22. Substrate p-nitrophenylphosphate

• 關聯藥證數量: 1

#One Touch SureStep Control Solution D-Glucose Solution .glycerol .dye. #One Touch Control Solution #SmartScan Control Solution D-Glucose Solution 0.1% Polyvinylacetate (aqueous emulsion) 14.0% Fumed silica 0.1% Sodium benzoate 0.2% Disodium EDTA 0.1% Copper phthalocyanine-tetrasulfonic acid Tetrasodium salt (blue dye) 0.0075% Antifoaming agent 0.02% #SureStepPro Linearity Test Kit (5 Glucose Levels) #SureStepHospital Glucose Control Solution (Low, Normal and High) D-Glucose Solution . preservative .other non-reactive ingredients. #One Touch Ultra Control Solution D-Glucose Solution 0.11% Sodium benzoate 0.2% Disodium EDTA 0.1% FD&C red dye 0.2% Viscosity-adjusting agent 8.0%

• 關聯藥證數量: 1

&#8226; Anti-HBc Total ReadyPack includes :\n(1) Lite Reagent 10.0 ml containing recombinant hepatitis B core antigen (~0.2μg/ml) labeled with acridinium ester in buffer with surfactant and preservatives.\n(2) Solid Phase 25.0 ml containing streptavidine coated paramagnetic microparticles preformed with biotinylated recombinant HBcAg (~0.2 μg/ml) in buffer with potassium thiocyanate (5.0%), bovine serum albumin,surfactant, and sodium azide (<0.1%).\n(3) Chaotrope Reagent 6.0 ml containing buffer with potassium thiocyanate (40%) and surfactant. \n(4) Ancillary Reagent 25.0 ml containing buffer with potassium thiocyanate (5.0%) and surfactant. \n(5) HBcT calibrator vials 7.0 ml/vial processed human plasma positive for HBc antibodies, bovine serum albumin, and preservatives.\n&#8226; HBcT quality control material 7.0 ml/vial containing processed human plasma negative and positive for \n anti-HBc with preservatives.\n

• 關聯藥證數量: 1

&#8226; HAV Total ReadyPack includes :\n(1) Lite Reagent 10.0 ml containing Monoclonal mouse anti-HAV (~0.1 μg/ml) labeled with acridinium ester and biotinylated monoclonal anti-HAV Fab fragment (~0.08 μg/ml) in phosphate buffer with bovine serum albumin, sodium azide (<0.1%) and preservatives.\n(2) Solid phase 17.5 ml containing streptavidin coupled to paramagnetic particles in phosphate buffer with bovine serum albumin, sodium azide (<0.1%) and preservatives.\n(3) Antigen reagent 10.0 ml containingHAV antigen (~0.06 μg/ml) in tricine buffer with bovine serum albumin, stabilizers, sodium azide (<0.1%), and surfactant. \n(4) Ancillary Reagent 25.0 ml containing cysteine in citrate buffer with EDTA and preservatives. \n(5) HAV Total calibrator vials: 2.0 ml/vial processed human plasma positive for anti-HAV antibodies with sodium azide (<0.1%).\n&#8226; HAV Total quality control material containing 7.0 ml/vial processed human plasma negative and positive for Anti-HAV antibodies with sodium azide (<0.1%).\n

• 關聯藥證數量: 1

&#8226; ReadyPack includes :\n(1) Lite Reagent 6.0 ml containing bovine serum albumin conjugated to monoclonal ati-TSH labeled with acridinium ester in HEPES buffered saline, mouse IgG, BSA, goat serum, surfactant and preservatives.\n(2) Solid Phase 21.0 ml containing anti-fluorescein monoclonal antibody covalently linked to paramagnetic particles (PMP) (~85 μg/ml) in HEPES buffered saline, BSA, goat serum, surfactant, and preservatives.\n(3) Ancillary Reagent 6.0 ml containing FITC conjugated to monoclonal anti-TSH (~3 μg/ml) in HEPES buffered saline, BSA, goat serum, surfactant, and preservatives. \n(4) Calibrator vials 2.0 ml/vial containing low and high levels of TSH in HEPES buffered equine serum with sodium azide (<0.1%) and preservatives. \n

• 關聯藥證數量: 1

&#8226; LH Cal1: 2 bottles, each for 1.0 mL of calibrator 1\n&#8226; LH Cal2: 2 bottles, each for 1.0 mL of calibrator 2\nLH (human) in two concentration ranges (approx. 1 mIU/mL and approx. 45 mIU/mL) in a human serum matrix.\n

• 關聯藥證數量: 1

&#8226; CPEPTID Cal1: 2 bottles, each for 1.0 mL of calibrator 1\n&#8226; CPEPTID Cal2: 2 bottles, each for 1.0 mL of calibrator 2\nC-peptide (synthetic) in two concentration ranges (approx. 0.167 nmol/L or\n0.5 ng/mL and approx. 6.67 nmol/L or 20 ng/mL) in an equine serum matrix.\n

• 關聯藥證數量: 1

&#8226; Instruction Leaflet: Giving full assay details.\n&#8226; QC Certificate: Indicating the expected performance of the batch\n&#8226; β2GP1 Coated Wells: 12 breakapart 8 well strips coated with human β2GP1 antigen. The plate is packaged in a re-sealable foil bag containing two desiccant pouches.\n&#8226; Type II Sample Diluent: 2 bottles containing 50 mL of buffer for sample dilution. Coloured yellow, ready to use.\n&#8226; Wash Buffer (20x Concentrate): 1 bottle containing 50 mL of a 20-fold concentrated buffer for washing the wells.\n&#8226; β2GP1 IgG Calibrators: 5 bottles each containing 1.2 mL of diluted human serum, with the following concentrations of anti- β2GP1 autoantibody: 300, 100, 33.3, 11.1, 3.7 U/mL. Ready to use.\n&#8226; β2GP1 IgG Positive Control: 1 bottle containing 1.2 mL of diluted human serum. The expected value is given on the QC certificate. Ready to use.\n&#8226; β2GP1 Negative Control: 1 bottle containing 1.2 mL of diluted human serum. The expected value is given on the QC certificate.

• 關聯藥證數量: 1

&#8226; SHBG Cal1: 2×1mL\n&#8226; SHBG Cal2: 2×1mL\nThe concentration of SHBG Cal1 is approx. 0 nmol/L; SHBG Cal2 contains approx. 40 nmol/L human SHBG in a human serum matrix.

• 關聯藥證數量: 1

( 1 test strip contains as below)1. Blood: Tetramethylbenzidine 12μg, Cumene hydroperoxide 5μL\n2. Bilirubin: Sodium nitrite 13μg, Substituted aniline diazonium salt q.s.\n3. Urobilinogen: 4-Diethylaminobenzaldehyde 26μg\n4. Ketone: Sodium nitroprusside 0.19 mg\n5. Protein: Terabromophenol blue 2μg\n6. Nitrite: p-arsanilic acid 56μg, 1,2,3,4-tetrahydrobenzoquinolin-3-ol 10μg\n7. Glucose: Glucose oxidase 1.1 unit, Peroxidase 0.13 unit, Potassium Iodide 0.3 mg \n8. pH: Methyl red 1.3μg, Bromothymol blue 9μg\n9. Specific Gravity: Bromothymol blue 18μg\n10. Leucocyte: Derivatized phenylpyrrole 9μg, Diazonium salt 7μg\n11. Ascorbic acid: 2, 6-Dichlorophenol Indophenol 0.75 mg

• 關聯藥證數量: 1

(+)-Pseudoephedrine Sulfate 80/200 contains not less than 98.5% and not more than 100.5% of (C10H15NO)2？H2SO4, calculated with reference to the dried substance.

• 關聯藥證數量: 1

(-)Phenylephrine Hydrochloride contains not less than 97.5 percent and not more than 102.5 percent of C9H13NO2‧HCl, calculated on the dried basis.

• 關聯藥證數量: 1

(1) 23.67 % w/w glucose oxidase (25 U/strip, from Aspergillus Niger)\n(2) 37.41% w/w potassium ferricyanide\n(3) 38.93% w/w non-reactive ingredients\n

• 關聯藥證數量: 1

(1) ADVIA Centaur CA 19-9A: lite reagent, solid phase\n(2) ACS: 180 CA 19-9: lite reagent, solid phase\nlite reagent: monoclonal mouse anti-CA 19-9 antibody (~ 1.5 ug/vial) labeled with acridinium ester in buffer with protein stabilizers, sodium azide, (0.1%), and preservatives.\nsolid phase: monoclonal mouse anti-CA 19-9 antibody (~ 0.54 mg/vial)\ncovalently coupled to paramagnetic particles in buffer with protein stabilizers, sodium azide, (0.1%), and preservtives.\n(3) Calibrator 9: After reconstitution, low or high levels of CA 19-9 in fetal bovine serum with sodium azide (<0.1%) and preservatives.\n

• 關聯藥證數量: 1

(1) ADVIA Centaur CKMB: lite reagent, solid phase lite reagent：monoclonal mouse anti-CK-MB antibody(~0.11 ug/mL) labeled with acridinium ester in buffer with sodium azide (0.11%), protein stabilizers, and preservatives. solid phase: monoclonal mouse anti-CK-BB antibody(~0.06 mgg/mL) covalently coupled to paramagnetic particles in buffer with protein stabilizers, sodium azide (0.1%), and preservatives.(2) CKMB Calibrator: After reconstitution, low or high levels of CK-MB in equine serum with gentamicin sulfate, preservatives, and protein stabilizers.

• 關聯藥證數量: 1

(1) Enzyme Reagent (R1)12U/mL of glycerol-3-phosphate oxidase(GPO),0.22mg/mL of N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline sodium salt (HDAOS),1.5U/mL of glycerol kinase (GK), 1.5mg/mL of adenosine-5’-triphosphate (ATP-2Na)(2) Enzyme Reagent B (R2)1400 U/mL of lipoprotein lipase (LPL),4.1mg/mL of 4-aminoantipyrine

• 關聯藥證數量: 1

(1) Enzyme\n0.1 mol/L Good’s buffer, pH 6.5 \ncontaining\n0.9 IU/mL hexokinase\n4 IU/mL glucose-6-phosphate dehydrogenase\n0.8 mmol/L β-nicotinamide adenine dinucleotide oxidized form\n(2) ATP Solution\n0.25 mol/L Tris buffer, pH 10.5 \ncontaining\n5.5 mmol/L adenosine 5’-triphosphate (ATP)\n

• 關聯藥證數量: 1

(1) Reagents\n1. Antibody Reagent\nAntibody monospecific for fibrinogen is supplied.\n2. Antibody Diluent: Polymer Diluent III\n60 mL of a polymeric enhancer solution is supplied.\n3. Sample Diluent: Diluent A\n50 mL Diluent A is supplied.\nContains 0.1% Sodium Azide.\n(2) Calibration Standard for Fibrinogen\nVial of Standard contains lyophilized pooled human plasma.\n(3) Control for Fibrinogen\nEach vial of Control contains lyophilized pooled human plasma.\n

• 關聯藥證數量: 1

(1) 12 microtiter strips (in 1 strip holder) (code VZV M)\n(2) 2.5ml VZV IgM negative control (green cap)\n(3) 2.5ml VZV IgM positive control (red cap)\n(4) 100 ml dilution buffer IgM (blue cap)\n(5) 12 ml Anti-IgM conjugate (white cap)\n(6) 50 ml washing solution (white cap)\n(7) 15 ml substrate reagent (black cap)\n(8) 15 ml stop solution (red cap)

• 關聯藥證數量: 1

(1) ACS: 180 DPD: lite reagent, solid phase\nlite reagent: monoclonal mouse anti-DPD antibody (~450 ng/vial) and polyclonal goat anti-mouse antibody (~195 ng/vial) labeled with acridinium ester in buffered saline with sodium azide (<0.1%) and preservatives.\nsolid phase: pyridinoline (~0.6 ug/vial) conjucated to avidin (~20 ug/vial) coupled to paramagnetic particels in buffered saline with sodium azide(<0.1%) and preservatives.\n(2) DPD 1,2,3 quality control material: after reconstitutuion, various levels of deoxypyridinoline in buffer with sodium chloride and preservatives.\n(3) DPD Calibrator: after reconstitution, low or high levels of deoxypyridinoline in buffer with sodium chloride and preservatives.

• 關聯藥證數量: 1

(1) ADVIA Centaur CA 125II:\n lite reagent: monoclonal mouse anti-M11 antibody labeled with acridinium ester and monoclonal mouse anti-OC 125 labeled with fluorescein in phosphate buffer with bovine serum albumin and preservatives \nsolid phase: monoclonal mouse anti-fluorescein antibody coupled to paramagnetic particles in phosphate buffer with bovine serum albumin and preservatives\n(2) CA 125II Calibrator: low or high level of CA125 in buffered human serum albumin with sodium azide and preservatives.

• 關聯藥證數量: 1

(1) ADVIA Centaur CA 15-3: lite reagent, solid phase, conjugate reagent.\n(2) CA 15-3 Calibrator: after reconstitution, low or high level of CA 15-3.

• 關聯藥證數量: 1

(1) ADVIA Centaur CEA: lite reagent, solid phase\n(2) ACS: 180 CEA: lite reagent, solid phase\nlite reagent: polyclonal rabbit anti-CEA antibody labeled with acridinium ester in phosphate buffered saline.\nsolid phase: monoclonal mouse anti-CEA antibody (~120 ug/mL) covalently coupled to paratmagnetic particles in phosphat buffered saline.

• 關聯藥證數量: 1

(1) ADVIA Centaur Cortisol: lite reagent, solid phase.\n(2) ACS: 180 Cortisol: lite reagent, solid pahse.\nlite reagent: cortisol (~1.7 ng/ml) labeled with acridinium ester in buffered saline with sodium salicylate (~50 mg/mL), sodium azide (0.1%) and preservatives.\nsolid phase: rabbit anti-cortisol antibody (~1.1 ug/mL) bound to monoclonal mouse anti-rabbit IgG antibody (~56 ug/mL) covalently coupled to paramagnetic particles in buffered saline with sodium azide (0.1%) and preservatives.

• 關聯藥證數量: 1

(1) ADVIA Centaur FOL: lite reagent, solid phase, binding protein, low calibrator, high calibrator(2) ADVIA Centaur FOL DTT/Releasing Agent: DTT, releasing agent(3) ACS: 180 aTG: lite reagent, solid phase, binding protein, DTT, releasing agent, low calibrator, high calibratorlite reagent: folate labeled with acridinium ester(~9.8 ng/mL) in buffer bovine serum albumin, sodium azide(0.1%), and preservativessolid phase: purified avidin (~20 ug/mL) covalently coupled to paramagnetic particles in buffer with human serum albumin and preservativesbinding protein: purified folate binding protein (~1.0 ug/mL) covalently coupled to biotin in buffer with bovine serum albumin and preservativesDTT: dithiothreitol (~95 mg/mL) in liquid formReleasing agent: sodium hydroxideCalibrators: after reconstitution, low or high levels of N-5-methyl-tetrahydrofolic acid in buffer with human serum albumin with sodium azide (<0.1%) and preservatives

• 關聯藥證數量: 1

(1) ADVIA Centaur FT3 : lite reagent, solid phase \n(2) ACS : 180 FT3 : lite reagent, solid phase \n lite reagent : monoclonal mouse anti-T3 antibodies (~8ng/mL) labeled with acridinium ester in HEPES buffer with protein stabilizer and sodium azide (0.1%)\n solid phase : T3 analog (~1.6 ug/mL) covalently coupled to paramagnetic particles in HEPES buffer with sodium azide (0.1%)\n

• 關聯藥證數量: 1

(1) ADVIA Centaur Insulin: lite reagent, solid phase. (2) ACS: 180 Insulin: liter reagent, solid phase.lite reagent: monoclonal mouse anti-insulin antibody labeled with acridinium ester in buffered saline with bovine serum albumin.solid phase: monoclonal mouse anti-insulin antibody covalently coupled to paramagnetic particles in buffered saline with bovine serum albumin.(3) IRI Calibrator: low or high levels of insulin in buffered saline with casein, potassium thiocyanate (3.89%).

• 關聯藥證數量: 1

(1) ADVIA Centaur T4: lite reagent, solid phase\n(2) ACS: 180 T4: lite reagent, solid phase, T3/T4 releasing agent\nlite reagent: monoclonal mouse anti-T3 antibody (~1 ug/mL) labeled with acridinium ester in sodium barbital buffer with protein stabilizers, ANS, EDTA, and sodium azide (0.1%)\nsolid phate: T4(~0.2 ug/mL) covalently coupled to paramagnetic particles in sodium barbital buffer with protein stabilizers, ANS, EDTA, and sodium azide (0.1%)\nT3/T4 releasing agent: 0.4 N sodium hydroxide

• 關聯藥證數量: 1

(1) ADVIA Centaur TSH-3: lite reagent, solid phase, low calibrator, high calibrator\n(2) ACS: 180 TSH-3: lite reagent, solid phase, low calibrator, high calibrator\nlite reagent: monoclonal mouse anti-TSH antibody (0.3 ug/mL)labeled with acridinium ester in HEPES buffered saline.\nsolid phase: polyclonal sheep anti-TSH antibody (53 ug/mL) covalently coupled to paramagnetic particles in HEPES buffered saline.\ncalibrators: after reconstitution, low and high levels of TSH in HEPES buffered equine serum.\n(3) master curve material: various levels of thyroid-stimulating hormone in lyophilized equine serum.

• 關聯藥證數量: 1

(1) ADVIA Centaur VB12: lite reagent, solid phase(2) ADVIA Centaur VB12 DTT/Releasing Agent(3) ACS:180 VB12: lite reagent, solid phase, releasing agent, DTTlite reagent: acridinium ester-labeled vitamin B12(~3 ng/mL) in buffered with sodium azide (0.1%), protein stabilizers, and preservativessolid phase: purified hog intrinsic factor (~0.025ug.mL) covalently coupled to paramagnetic particles in buffered with sodium azide (0.1%), protein stabilizers, cobinamide, and preservativesreleasing agent: sodium hydroxide (~0.30 N) with potassium cyanide (~0.05mg/mL)DTT: dithiothreitol(~105mg/mL)

• 關聯藥證數量: 1

(1) ADVIA Centaur aTG: lite reagent: human thyroglobulin (~0.38 ug/mL) labeled with acridinium ester in buffer with BSA, sodium azide (<0.1%), protein stabilizers, and preservatives.solid phase: polyclonal human anti-Tg antibody (~1.98 ug/mL) bound to polyclonal goat anti-human antibody (~49.5 ug/mL) covalently coupled to paramagnetic particles in buffer with BSA, sodium azide (<0.1%) and preservatives.(2) aTG, 1,2, quality control material (3 vials for each level, 2 mL/vial): various levels of anti-Tg in human plasma with sodium azide (<0.1%) and preservatives.(3) Calibrator 1 (2 vials for each level, 1 mL/vial): low or high levels of anti-Tg in human plasma with sodium azide (<0.1%) and preservative

• 關聯藥證數量: 1

(1) ADVIA Centaur cTnI: lite reagent, solid phase, low calibrator U, high calibrator U(2) ACS:180 cTnI: lite reagent, solid phase, low calibrator U, high calibrator Ulite reagent: polyclonal goat anti-cTnI antibody labeled with acridinium ester in tris buffer with protein stabilizers and preservativessolid phase: monoclonal mouse anti-cTnI antibodies covalently coupled to paramagnetic particles in tris buffer with protein stabilizers and preservativescalibrators: after reconstitution, low or high levels of cardiac troponin I and myoglobin in goat serum with preservatives and stabilizers

• 關聯藥證數量: 1

(1) ADVIA Centaur iPTH: lite reagent, solid phase. \n(2) ACS: 180 iPTH: lite reagent, solid phase. \nlite reagent: biotinylated polyclonal goat anti-human PTH (39-84 region) antibody (~8 ug/mL) and acridinium ester-labeled polyclonal goat anti-human PTH (1-34 N-terminal) antibody (~1 ug/mL). \nsolid phase: streptavidin (~0.4 mg/mL) covalently coupled to paramagnetic latex particles in phosphate buffered saline with goat IgG, bovine gamma globulin.\n(3) iPTH 1,2,3,quality control material: 1 mL/vial after reconstitution, various levels of intact PTH in phosphate buffered saline with equine serum. \n(4) iPTH Calibrator: 1 mL/vial after reconstitution, low or high levels of intact PTH.

• 關聯藥證數量: 1

(1) ADVIA Centaur tIgE: lite reagent, solid pahse.\n(2) ACS: 180 IgE: lite reagent, solid phase.\nlite reagent: goat anti-human IgE antibody (~2.4 ug/mL) labeled with acridinium ester.\nsolid phase: mouse anti-human IgE antibody (~0.02 mg/mL) covalently coupled to paramagnetic particles.\n

• 關聯藥證數量: 1

(1) Alkaline\n 0.10 mol/L sodium tetraborate containing sodium hydroxide\n(2) Additional A\n 0.20 mol/L periodic acid\n(3) Picric Acid\n 8.7 mmol/L 2,4,6-trinitrophenol (picric acid)\n(4) Additional B\n containing diethanolamine\nCreatinine Standard Solution contains creatinine and stabilizer.\n

• 關聯藥證數量: 1

(1) Buffer\n 50 mmol/L Good’s buffer (pH 7.4)\n(2) RF Reagent\n Heat-aggregated human IgG (1mL/mL) \n(3) RF TIA Calibrator 1, 2, 3, 4, 5\n Rheumatoid factor from human sera\n

• 關聯藥證數量: 1

(1) Buffer\n Good’s buffer, pH 8.2

• 關聯藥證數量: 1

(1) Enzygnost Anti-HSV/IgG Test Plate(2pcs): Microtitration plate coated with inactivated HSV Ag.\n(2) Anti-Human IgG/POD Conjugate(1 ×1mL): F(ab)’ fragment of rabbit Ab to human IgG, conjugated with peroxidase, in TRIS/HCl buffer with polygeline and dye(patent blue, tartrazine), preservative(phenol≦1g/L).\n(3) Conjugate Buffer Microbiol (4 ×12.5mL): EDTA in phosphate buffer with Tetronic and BSA and preservatives (gentamicin: ~100 mg/L, 5-chloro-2-methyl-isothiazole-3-one: ~6mg/L, 2-methyl-4-isothiazole-3-one: ~2mg/L). \n(4) Anti-HSV Reference P/N(1 ×0.4mL): human serum containing IgG Ab to HSV Ag in TRIS/HCl buffer with Humanalbin and preservatives (amphotericin B: ~5 mg/L, gentamicin:~100 mg/L).\n(5) Sample Buffer POD(2 ×50mL): TRIS/HCl buffer with Tween 20, polygeline and bovine serum and preservatives (amphotericin B: ~5 mg/L, gentamicin: ~100 mg/L).\n

• 關聯藥證數量: 1

(1) Enzyme Color A\n0.1 mol/L Goods buffer, pH 7.0\ncontaining\n2 U/mL peroxidase\n3.5 IU/mL ascorbate oxidase\n0.51 mmol/L N-(3-sulfopropyl)-3-methoxy-5-methylaniline\n(2) Enzyme Color B\n0.1 mol/L Goods buffer, pH 7.0\n0.88 IU/mL uricase\n4 mmol/L 4-aminoantioyrine

• 關聯藥證數量: 1

(1) Enzyme Color A\n0.2 mol/L Goods buffer, pH7.0 containing 2.1 U/mL peroxidase (Horseradish), 2.5 U/mL ascorbate oxidase (Acremonium sp.) and 0.36 mmol/L F-DAOS.

• 關聯藥證數量: 1

(1) Enzyme: 0.1M Good’s (BES) buffer, pH 7.7 Glucoamylase 16 IU/mL a-glucosidase 20 IU/mL (2) Substrate: 10 mM Good’s (BES) buffer, pH 5.0 BG5P 4.2 mmol/L

• 關聯藥證數量: 1

(1) Goat anti mouse IgG (22%)\n(2) Goat anti α-hCG (38%)\n(3) Mab anti β-hCG (40%)

• 關聯藥證數量: 1

(1) IMMUNOCHROMATOGRAPHIC TESTING DEVICE: 25PCS OR 50 PCS 1.DEVICE COATED MEMBRANE(7MM): COAT ANTI-MOUSE ANTIBODY FOR REFERENCE LINE 0.001G HCV ANTIGEN SOLUTION FOR TEST LINE 0.001G 2.FIBERGLASS(7MM): COLLOIDAL GOLD AU-AB/AG CONJUGATE SOLUTION FOR FIBERGLASS COATING 0.014G

• 關聯藥證數量: 1

(1) Latex solution 8mL 1 bottle\n Latex coated with Rabbit anti-IgE polyclonal antibody\n 8mL/bottle \n(2) Stabilizing solution 18mL 1 bottle \n \n

• 關聯藥證數量: 1

(1) OC-LIGHT: 1.PVA binding glass fiber, blue latex, bovine serum albumin, Tris (hydroxymethyl) aminomethane, sucrose, mouse anti-human IgG, rabbit anti-human IgG. 2.Nitrocellulose, mouse anti-human IgG, anti-mouse IgG rabbit IgG, sodium monophosphate, sodium diphosphate, sodium chloride.\n(2) Sampling bottle: HEPES, sodium hydroxide, sodium chloride, sodium azide, bovine serum albumin.\n

• 關聯藥證數量: 1

(1) Procleix Ultrio Plus Assay \nInternal Control Reagent、Target Capture Reagent、Target Enhancer Reagent、Amplification Reagent、 Enzyme Reagent、Probe Reagent、Selection Reagent、Negative Calibrator、HIV-1 Positive Calibrator、HCV Positive Calibrator、HBV Positive Calibrator \nReagents provided separately:\n(2) Procleix Ultrio Plus HIV-1, HCV and HBV Discriminatory Probe Reagents \nHIV-1 Discriminatory Probe Reagent、HCV Discriminatory Probe Reagent、HBV Discriminatory Probe Reagent \n(3) Procleix Assay Fluids\nWash Solution、Oil、Buffer for deactivation Fluids \n(4) Procleix AutoDetect Reagents\nAuto Detect 1、Auto Detect 2 \n(5) Procleix System Fluid Preservative \n(6) Procleix Ultrio Plus TIGRIS Controls\nProcleix Ultrio Plus TIGRIS Negative Control、Procleix Ultrio Plus TIGRIS HIV-1 Control、Procleix Ultrio Plus TIGRIS HCV Control、Procleix Ultrio Plus TIGRIS HBV Control

• 關聯藥證數量: 1

(1) Substrate-Enzyme 35 mmol/L Tris buffer, pH 9.0 (25°C) containing 100 mmol/L L-aspartate 0.031 mmol/L β-nicotinamide adenenine dinucleotide reduced from (NADH, form yeast) 2900 IU/L (37°C) malate dehydrogenase (MDH, from microorganism) 4000 IU/L (37°C) lactate dehydrogenase (LDH, from microorganism)(2) α-KG 178 mmol/L Tris buffer, pH 5.6 (25°C) containing 420 mmol/L L-aspartate 31 mmol/L α-ketoglutarate

• 關聯藥證數量: 1

(1) Test Cells: freeze-dried equivalent of 3 ml of 1% suspension of aldehyde treated, tanned turkey erythrocytes coated with human thyroglobulin dispersed in phosphate buffered saline pH 7.2, containing 5% sucrose, 1.5% normal rabbit serum and 0.01% Bronopol.\n(2) Control Cells: freeze-dried equivalent of 3 ml of a 1% suspension of aldehyde treated, tanned turkey erythrocytes dispersed in phosphate buffered saline pH 7.2, containing 5% sucrose, 1.5% normal rabbit serum and 0.01% Bronopol.\n(3) Diluent: 25 ml of isotonic saline containing normal human serum negative for HBsAg and antibodies to HIV-1 and HIV-2 and HCV, normal turkey serum, human thyroglobulin and 0.1% sodium azide.\n(4) Positive Control Serum: 1.0 ml of sheep anti-thyroglobulin serum having a haemagglutinating titre of approximately 1/640 with Test Cells. The serum contains 0.1% sodium azide.\n(5) Negative Control Serum: 1.0 ml of normal human serum negative for HBsAg and antibodies to HIV-1 and HIV-2 and HCV. The serum contains 0.1% sodium azi

• 關聯藥證數量: 1

(1) Test Cells: freeze-dried equivalent of 3 ml of 1% suspension of aldehyde treated, tanned turkey erythrocytes coated with microsomal antigen dispersed in phosphate buffered saline pH 7.2, containing 5% sucrose, 1.5% normal rabbit serum and 0.01% Bronopol.\n(2) Control Cells: freeze-dried equivalent of 3 ml of a 1% suspension of aldehyde treated, tanned turkey erythrocytes dispersed in phosphate buffered saline pH 7.2, containing 5% sucrose, 1.5% normal rabbit serum and 0.01% Bronopol.\n(3) Diluent: 25 ml of isotonic saline containing normal human serum negative for HBsAg and antibodies to HIV-1 and HIV-2 and HCV, normal turkey serum, human thyroglobulin and 0.1% sodium azide.\n(4) Positive Control Serum: 1.0 ml of diluted rabbit anti-microsomal serum. Contains 0.1% sodium azide.\n(5) Negative Control Serum: 1.0 ml of diluted normal human serum negative for HBsAg and antibodies to HIV-1 and HIV-2 and HCV. Contains 0.1% sodium azide.\n\n

• 關聯藥證數量: 1

(1).IMMUNOCHROMATOGRAPHIC TESTING DEVICE : 1 PCS 1.DEVICE COATED MEMBRANE (7MM): COATING REFERENCE LINE SOLUTION 0.001G HIV 1/2 TEST LINE SOLUTION 0.001 2.FIBERGLASS (7MM): HIV1/2 COLLOIDAL GOLD CONJUGATE SOLUTION FOR FIBERGLASS COATING GP-41 0.014G HIVE1/2 COLLOIDAL GOLD CONJUGATE SOLUTION FOR FIBERGLASS COATING GP-36 0.014G

• 關聯藥證數量: 1

(1)ACS: 180 BR(#116272, #116271):\nlite reagent: monoclonal mouse anti-CA 15-3 antibody (~3 ug/vial) labeled with acridinium ester in buffered saline with preservatives.\nsolid phase: human CA 15-3 (~9 U/vial) covalently coupled to paramagnetic particels in buffere with preservatives.\npretreatment reagent: sodium hydroxide (0.55 N).\n(2)Calibrator G(#672186, #672185): after reconstitution, low or high levels of CA 15-3 in equine serum with sodium azide (0.1%) and preservatives.

• 關聯藥證數量: 1

(1)ACS： OV：\n lite reagent：monoclonal mouse antibody to CA 125 (~ 6 ug/vial) labeled with acridinium ester in phosphate buffer with protein stabilizers, sodium azide (<0.1%), and preservatives\n solid phase：monoclonal mouse antibody to CA 125 (~ 0.55 mg/vial) coupled to paramagnetic particles in in phosphate buffer with protein stabilizers, sodium azide (<0.1%), and presrvatives\n(2)Calibrator X：after reconstitution, low or high levels of CA 125 in buffered human serum albumin with sodium azide (<0.1%) and preservatives

• 關聯藥證數量: 1

(1)ADVIA Centaur CpS：lite reagent,solid phase\n(2)ACS：180 CpS：lite reagent,solid phase \nlite reagent：monoclonal mouse anti-C-peptide antibody(0.29 ug/mL)labeled with acridinium ester in phosphate buffer with bovine serum albumin,sodium azide (<0.1%),and preservatives\nsolid phase：monoclonal mouse anti-C-peptide antibody(~2.3 ug/mL)covalently coupled to paramagnetic particles in phosphate buffer with bovine serum albumin,sodium azide(<0.1%),and preservatives\n

• 關聯藥證數量: 1

(1)ADVIA Centaur FER：lite reagent,solid phase\n(2)ACS：180 FER：lite reagent,solid phase\nlite reagent：polyclonal goat anti-ferritin antibody labeled with acridinium ester in HEPET buffer\nsolid phase：monoclonal mouse anti-ferritin antibody covalently coupled to paramagnetic particles in sodium barbital buffer

• 關聯藥證數量: 1

(1)Albumin Antiserum（HAD1）：22 mL of anti-human albumin antiserum supplied in liquid form.\n(2)125I Albumin (HAD2）：Lyophilized iodinated human serum albumin.\n(3) Albumin Calibrators(HAD3 8）：labed A through F, of lyophilized calibrators.

• 關聯藥證數量: 1